Eukroma Cream
$ 47,00 – $ 151,00Price range: $ 47,00 through $ 151,00
Eurax
$ 49,00 – $ 187,00Price range: $ 49,00 through $ 187,00
Eulexin
$ 51,00 – $ 475,00Price range: $ 51,00 through $ 475,00
Eulexin is a highly effective oral nonsteroidal antiandrogen medication specifically indicated for the treatment of metastatic prostatic carcinoma. This medication works by blocking the action of testosterone, which helps to inhibit the growth and spread of hormone-sensitive cancer cells. It is commonly used as a primary component of combination therapy to manage advanced stages of prostate cancer more effectively. By preventing androgens from binding to receptors in the prostate, the drug provides a targeted approach to slowing disease progression. This quality-tested medication offers a reliable therapeutic option for men focused on comprehensive prostate health management.
Active substance: Flutamide
SKU:
Eulexin
Category: Cancer
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Eulexin belongs to a class of medications known as nonsteroidal antiandrogens. It is indicated for use in combination with a luteinizing hormone-releasing hormone (LHRH) agonist for the management of locally confined Stage B2-C or metastatic Stage D2 prostate carcinoma. Because of its pharmacological activity and potential risks, Eulexin is available strictly by prescription in the United States.
Optimal therapeutic outcomes with Eulexin require adherence to prescribed dosing regimens and routine clinical monitoring. Patients must remain aware of critical safety precautions, particularly regarding liver enzyme evaluations, during treatment.
| Parameter | Details |
|---|---|
| Drug name | Eulexin |
| Active ingredient (INN) | Flutamide |
| Therapeutic class | Nonsteroidal antiandrogen |
| Dosage form | Oral capsule (125 mg) |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) only |
Overview and Dosing
How the drug works
Flutamide acts as a competitive inhibitor of androgen binding at cellular receptors. In androgen-sensitive tissues such as the prostate gland, male hormones like testosterone and dihydrotestosterone (DHT) stimulate cell growth. Flutamide blocks the cellular uptake of androgen as well as its nuclear binding in target tissue. When administered alone, compensatory increases in luteinizing hormone (LH) and testosterone secretion may occur due to blockade of the hypothalamic-pituitary negative feedback loop. Therefore, it is clinically paired with LHRH agonists, such as leuprolide acetate, which suppress pituitary gonadotropin release. This dual approach achieves complete androgen blockade, effectively inhibiting hormone-responsive prostate carcinoma growth.
What it’s used for
Eulexin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic prostate cancer (Stage D2) when prescribed in combination therapy with LHRH agonists. It is also indicated in combination with LHRH agonists for the initiation of therapy and reduction of tumor volume prior to radiation therapy in Stage B2 and Stage C prostate cancer. Any use of Eulexin outside of prostate carcinoma, such as for hyperandrogenic conditions in females, represents an off-label application. Off-label prescribing of flutamide is not FDA-approved and carries specific risks, particularly regarding potential fetal toxicity in female patients of childbearing potential. Therapy must always be directed by a qualified oncologist or prescribing physician.
Dosing schedule
The standard adult dosage of Eulexin for prostate carcinoma is 250 mg taken orally three times daily at 8-hour intervals, total daily dose of 750 mg. Dosing is typically initiated concurrently with the administration of an LHRH agonist to prevent the transient disease flare that can occur when LHRH agonists are used alone. Capsules should be swallowed whole with water. Therapy is continued until disease progression occurs or until unacceptable toxicity develops. Patients should not alter their dosage or discontinue administration without explicit guidance from their healthcare provider, as consistent antiandrogen levels are necessary for therapeutic efficacy.
What happens in the body
Following oral administration, flutamide is rapidly and completely absorbed from the gastrointestinal tract. Flutamide undergoes extensive first-pass hepatic metabolism to convert into its primary active metabolite, 2-hydroxyflutamide, along with several minor inactive metabolites. Plasma levels of unchanged flutamide remain low, whereas 2-hydroxyflutamide reaches peak plasma concentrations within approximately 2 hours after dosing. Hydroxyflutamide exhibits high plasma protein binding, ranging from 92% to 94%. The elimination half-life of the active metabolite hydroxyflutamide is approximately 6 hours in adults, reaching steady-state levels following repeated administration. Excretion occurs primarily via renal clearance, with urine accounting for the majority of the dose excreted within 72 hours.
Safety and Frequently Asked Questions
Compatibility with other medicines
Eulexin can interact with several co-administered medications, necessitating dosage adjustments or therapeutic monitoring. In patients receiving long-term oral anticoagulant therapy, such as warfarin, co-administration of flutamide may prolong prothrombin time and increase the international normalized ratio (INR). Anticoagulant dosages often require reduction and careful INR monitoring upon initiating or stopping Eulexin. Additionally, since flutamide undergoes hepatic metabolism involving cytochrome P450 enzyme pathways, concurrent use of other potentially hepatotoxic medications should be approached with caution to minimize the risk of cumulative liver injury. Patients must provide their full medication list to their prescriber prior to beginning therapy.
Adverse reactions
The most common side effects associated with Eulexin when combined with LHRH agonists include hot flashes, loss of libido, erectile dysfunction, nausea, vomiting, diarrhea, and gynecomastia (breast tissue enlargement or tenderness). Gastrointestinal reactions such as diarrhea may range from mild to severe; severe diarrhea requires medical management or temporary dosage modification. Less frequently, patients may experience elevated serum transaminases, insomnia, fatigue, elevated blood pressure, or neuromuscular discomfort. Urine discoloration to an amber or yellow-green color is a known, benign outcome of flutamide excretion. Patients should report any persistent or worsening adverse reactions promptly to their prescribing physician.
Important precautions
Eulexin carries a significant boxed warning regarding severe liver toxicity. Hepatic failure, hospitalization, and fatal outcomes have been reported during flutamide therapy. Serum transaminase levels (ALT and AST) must be measured prior to starting treatment, monthly for the first 4 months, and periodically thereafter, or at the first symptom of hepatic dysfunction (such as jaundice, dark urine, persistent nausea, or right upper quadrant abdominal pain). Treatment should be discontinued immediately if ALT levels exceed twice the upper limit of normal. Eulexin is contraindicated in patients with severe baseline hepatic impairment. Furthermore, Eulexin is not indicated for use in women or pediatric populations.
Red flags
Patients taking Eulexin must seek immediate emergency medical care if they experience symptoms indicative of acute liver injury. These include yellowing of the skin or eyes (jaundice), dark brown urine, light-colored stools, severe loss of appetite, or right upper abdominal tenderness. Immediate evaluation is also required if signs of a severe allergic reaction occur, such as facial, lip, or tongue swelling, difficulty breathing, or severe generalized skin rash. Furthermore, unexpected chest pain, severe shortness of breath, or sudden severe confusion require urgent medical attention.
If you skip a dose
If a dose of Eulexin is missed, the patient should take it as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the normal 8-hour dosing schedule resumed. Patients must never double the dose or take extra capsules to make up for a missed dose. Maintaining consistent therapeutic concentrations is important, so establishing a regular routine or using medication reminders can help prevent missed doses.
What to avoid while taking it
Eulexin may be taken with or without food. However, consuming alcohol while taking Eulexin is strongly discouraged. Both alcohol and flutamide undergo metabolism in the liver; concurrent alcohol consumption can increase stress on hepatic tissue and elevate the risk of liver toxicity. Additionally, alcohol may exacerbate central nervous system side effects such as fatigue or dizziness. Patients should discuss dietary habits and alcohol consumption with their physician before starting therapy.
Special populations
Eulexin is specifically formulated and indicated for adult male patients with prostate cancer. It is not indicated for use in female patients. Flutamide can cause fetal harm when administered to a pregnant female. Elderly patients may safely receive Eulexin provided their hepatic function is adequate, though close monitoring for age-related renal or cardiac comorbidities is recommended. Safety and effectiveness in pediatric patients have not been established. Patients with mild renal impairment generally do not require dose adjustments, but severe renal impairment requires careful clinical evaluation.
Common questions
How long is Eulexin therapy typically continued?
Eulexin treatment is generally continued for as long as the disease remains responsive to therapy or until unacceptable toxicity occurs. In neoadjuvant settings prior to radiation, treatment usually lasts for a defined period specified by the oncologist, often starting 8 weeks before radiation therapy. Discontinuation decisions depend on regular laboratory tests, imaging, and prostate-specific antigen (PSA) monitoring.
Is urine discoloration expected while taking Eulexin?
Yes, urine discoloration ranging from dark amber to a greenish-yellow hue is a known side effect of flutamide. This effect occurs due to the excretion of flutamide metabolites through the urinary tract. While it is generally harmless, patients should distinguish between amber urine discoloration and true dark urine associated with liver injury, which is usually accompanied by symptoms like abdominal pain or jaundice.
What liver function tests are necessary during Eulexin treatment?
Baseline blood tests measuring alanine aminotransferase (ALT) and aspartate aminotransferase (AST) must be conducted before starting Eulexin. These tests are repeated monthly during the first 4 months of treatment and periodically thereafter. If at any time ALT levels rise above twice the upper limit of normal, or if signs of liver injury appear, the medication should be stopped immediately.
Can Eulexin be taken alongside over-the-counter pain relievers like acetaminophen?
Caution is required when taking acetaminophen or other medications that affect the liver while on Eulexin. Because flutamide carries a risk of liver toxicity, combining it with high doses of acetaminophen can increase the stress placed on hepatic tissues. Patients should consult their prescribing physician or pharmacist before taking any over-the-counter medications.
Why is Eulexin prescribed together with an LHRH agonist rather than alone?
Using an LHRH agonist alone initially causes a temporary spike in LH and testosterone levels, which can lead to a tumor flare. Taking Eulexin blocks the androgen receptors, preventing testosterone from stimulating cancer cells during this initial surge. Combined therapy achieves complete androgen blockade, blocking both testicular testosterone production and adrenal androgen activity at the cellular receptor site.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
250mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Arimidex
$ 194,00 – $ 441,00Price range: $ 194,00 through $ 441,00
Active substance: Anastrozole
More Details
This product has multiple variants. The options may be chosen on the product page
Cytoxan
$ 51,00 – $ 420,00Price range: $ 51,00 through $ 420,00
Active substance: Cyclophosphamide
More Details
This product has multiple variants. The options may be chosen on the product page
Fenbendazole
$ 38,00 – $ 231,00Price range: $ 38,00 through $ 231,00
Active substance: Fenbendazole
More Details
This product has multiple variants. The options may be chosen on the product page
Hydrea
$ 64,00 – $ 541,00Price range: $ 64,00 through $ 541,00
Active substance: Hydroxyurea
More Details
This product has multiple variants. The options may be chosen on the product page
Leukeran
$ 60,00 – $ 1 224,00Price range: $ 60,00 through $ 1 224,00
Active substance: Chlorambucil
More Details
This product has multiple variants. The options may be chosen on the product page
Melatonin
Anti-Inflammatories, AntiConvulsants, AntiParasitics, Cancer, Dementias, HIV, Migraine, Osteoporosis, Respiratory Tract
$ 46,00 – $ 201,00Price range: $ 46,00 through $ 201,00
Active substance: Melatonin
More Details
This product has multiple variants. The options may be chosen on the product page
Premarin
$ 379,00 – $ 705,00Price range: $ 379,00 through $ 705,00
Active substance: Conjugated Estrogens
More Details
This product has multiple variants. The options may be chosen on the product page
Zofran
$ 44,00 – $ 258,00Price range: $ 44,00 through $ 258,00
Active substance: Ondansetron
More Details
This product has multiple variants. The options may be chosen on the product page
